Home » News » AIM News » Sativa Investments: Medicinal cannabis available on prescription from Nov 1st
Sativa Investments PLC

Sativa Investments: Medicinal cannabis available on prescription from Nov 1st

The Home Secretary Sajid Javid, has announced that medicinal cannabis oil will be available for medicinal use only in England, Scotland and Wales on prescription by November 1st. The new law will not be limiting the types of conditions that can be considered for treatment which gives doctors the freedom to prescribe without the need to seek approval from an expert panel.

Geremy Thomas, founder and CEO of Sativa Investments, the UK’s first medicinal cannabis investment vehicle, said:

“This is further good news for the industry and Sativa looks forward to the details of the Home Office’s vision. There will of course be more competition from foreign companies who will apply for import licences and Sativa itself will exploit these future opportunities here in Britain.

Sativa will continue to develop and run its pan-European seed to consumer strategy, delivering on all components of the end-to-end process for the development of medicinal cannabis.”

You can read the the full article here: https://www.standard.co.uk/news/uk/medicinal-cannabis-oil-will-be-available-on-prescription-by-next-month-sajid-javid-says-a3959866.html

Sativa Investments (NXT:SATI) seeks to invest in global companies which are well-placed to take advantage of the dynamic regulatory environment surrounding medical Cannabis. Its investment strategy focuses on production, pharmacology, testing and compliance, R&D commercialisation, and sales and marketing.